No Data
No Data
Does YSB (HKG:9885) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious
Insiders Own 30% of YSB Inc. (HKG:9885) in Spite of Selling Recently and the Recent Dip May Have Hurt Them
Key Insights YSB's significant insider ownership suggests inherent interests in company's expansion 51% of the business is held by the top 4 shareholders Recent sales by insiders Every investor
YSB Trustee Buys Back Shares For Incentive Scheme
YSB (HKG:9885), through its trustee, repurchased 100,000 of the pharmaceuticals sales platform's shares at HK$8.21 apiece for HK$821,186, according to a Wednesday filing with the Hong Kong bourse. The
Pharmacist Gang (09885.HK): Trustee buys back 100,000 shares according to share incentive plan
Gelonghui, April 24, 丨 Pharmacist Gang (09885.HK) issued an announcement. On April 24, 2024, according to the trust arrangement between the company and the trust agency, the trustee bought back 100,000 shares of the company on the market to meet the rewards granted under the share incentive plan. The total cost was HK$821,186, with an average price of HK$8.21 per share. Under the share incentive plan, the company may direct the trustee to make further repurchases of additional shares, and from time to time publish separate voluntary announcements regarding the relevant repurchases. The board of directors believes that the company's current stock price is lower than its intrinsic value and may not fully reflect the public
YSB Widens Loss by 114% in 2023
YSB (HKG:9885) recorded a 114% rise in attributable loss for the year ended Dec. 31, 2023, to 3.19 billion yuan from 1.49 billion yuan during the year-ago period, a Friday filing on the Hong Kong bour
YSB: 2023 Annual Report
No Data